Stay updated on Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page.

Latest updates to the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page
- Check7 days agoChange DetectedThe study's record history update designates Scott T. Aaronson, M.D. as the last verifier and adds explicit 'Last verified' and 'Last known status was' labels for the v3.6.0 revision, replacing the prior verifier and revision details from v3.5.5.SummaryDifference2%

- Check14 days agoChange DetectedThe record history shows a new Revision: v3.5.5 entry added, replacing the previous Revision: v3.5.4, indicating a minor platform update to the study record page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe Record History now shows revision v3.5.4, replacing the previous v3.5.3, indicating a new version of the page was published.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page’s footer/update label changes from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor system/version update rather than a change to the underlying study record.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision history updated to include v3.5.2; v3.5.0 was removed.SummaryDifference0.1%

- Check93 days agoChange DetectedThe history now shows an added revision v3.5.0 and the removal of v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page.